Published: by:165

Autism, attention deficit/hyperactivity disorder (ADHD), mental retardation, dyslexia, and other biologically based disorders of brain development affect between 400,000 and 600,000 of the 4 million children born in the United States each year. The Centers for Disease Control and Prevention (CDC) has reported that autism spectrum disorder (ASD) now affects 1.13% (1 of 88) of American children (CDC 2012) and ADHD affects 14% (CDC 2005; Pastor and Reuben 2008). Treatment of these disorders is difficult; the disabilities they cause can last lifelong, and they are devastating to families. In addition, these disorders place enormous economic burdens on society (Trasande and Liu 2011).

Although discovery research to identify the potentially preventable causes of neuro-develop-mental disorders (NDDs) has increased in recent years, more research is urgently needed. This research encompasses both genetic and environ-mental studies.

Genetic research has received particular investment and attention (Autism Genome Project Consortium et al. 2007; Buxbaum and Hof 2011; Fernandez et al. 2012; O’Roak et al. 2011; Sakurai et al. 2011) and has demonstrated that ASD and certain other NDDs have a strong hereditary component (Buxbaum and Hof 2011; Sakurai et al. 2011). Linkage studies have identified candidate autism susceptibility genes at multiple loci, most consistently on chromosomes 7q, 15q, and 16p (Autism Genome Project Consortium et al. 2007; Sakurai et al. 2011). Exome sequencing in sporadic cases of autism has detected new mutations (O’Roak et al. 2011), and copy number variant studies have identified several hundred copy number variants putatively linked to autism (Fernandez et al. 2012). The candidate genes most strongly implicated in NDD causation encode for proteins involved in synaptic architecture, neuro-transmitter synthesis (e.g., ©-amino-butyric acid serotonin), oxytocin receptors, and cation trafficking (Sakurai et al. 2011). No single anomaly predominates. Instead, autism appears to be a family of diseases with common pheno-types linked to a series of genetic anomalies, each of which is responsible for no more than 2–3% of cases. The total fraction of ASD attributable to genetic inheri-tance may be about 30–40%.

Exploration of the environmental causes of autism and other NDDs has been catalyzed by growing recognition of the exquisite sensitivity of the developing human brain to toxic chemicals (Grandjean and Landrigan 2006). This susceptibility is greatest during unique “windows of vulnerability” that open only in embryonic and fetal life and have no later counter-part (Miodovnik 2011). “Proof of the principle” that early exposures can cause autism comes from studies linking ASD to medications taken in the first trimester of pregnancy—thalidomide, misoprostol, and valproic acid—and to first-trimester rubella infection (Arndt et al. 2005; Daniels 2006).

This “proof-of-principle” evidence for environmental causation is supported further by findings from prospective birth cohort epidemio-logical studies, many of them supported by the National Institute of Environmental Health Sciences (NIEHS). These studies enroll women during pregnancy, measure prenatal exposures in real time as they occur, and then follow children longitudinally with periodic direct examinations to assess growth, development, and the presence of disease. Prospective studies are powerful engines for the discovery of etiologic associations between prenatal exposures and NDDs. They have linked autistic behaviors with prenatal exposures to the organophosphate insecticide chlorpyrifos (Eskenazi et al. 2007) and also with prenatal exposures to phthalates (Miodovnik et al. 2011). Additional prospective studies have linked loss of cognition (IQ), dyslexia, and ADHD to lead (Jusko et al. 2008), methyl-mercury (Oken et al. 2008), organophosphate insecticides (London et al. 2012), organo-chlorine insecticides (Eskenazi et al. 2008), polychlorinated biphenyls (Winneke 2011), arsenic (Wasserman et al. 2007), manganese (Khan et al. 2011), polycyclic aromatic hydrocarbons (Perera et al. 2009), bisphenol A (Braun et al. 2011), brominated flame retardants (Herbstman et al. 2010), and perfluorinated compounds (Stein and Savitz 2011).

Toxic chemicals likely cause injury to the developing human brain either through direct toxicity or inter-actions with the genome. An expert committee convened by the U.S. National Academy of Sciences (NAS) estimated that 3% of neuro-behavioral disorders are caused directly by toxic environ-mental exposures and that another 25% are caused by inter-actions between environmental factors, defined broadly, and inherited susceptibilities (National Research Council 2000). Epigenetic modification of gene expression by toxic chemicals that results in DNA methyla-tion, histone modification, or changes in activity levels of non-protein-coding RNA (ncRNAs) may be a mechanism of such gene–environment interaction (Grafodatskaya et al. 2010). Epigenetic “marks” have been shown to be able to influence gene expression and alter high-order DNA structure (Anway and Skinner 2006; Waterland and Jirtle 2004).

A major unanswered question is whether there are still undiscovered environ-mental causes of autism or other NDDs among the thousands of chemicals currently in wide use in the United States. In the past 50 years, > 80,000 new synthetic chemicals have been developed (Landrigan and Goldman 2011). The U.S. Environmental Protection Agency has identified 3,000 “high production volume” (HPV) chemicals that are in widest use and thus pose greatest potential for human exposure (Goldman 1998). These HPV chemicals are used today in millions of consumer products. Children and pregnant women are exposed extensively to them, and CDC surveys detect quantifiable levels of nearly 200 HPV chemicals in the bodies of virtually all Americans, including pregnant women (Woodruff et al. 2011).

The significance of early chemical exposures for children’s health is not yet fully understood. A great concern is that a large number of the chemicals in widest use have not undergone even minimal assessment of potential toxicity, and only about 20% have been screened for potential toxicity during early development (Landrigan and Goldman 2011). Unless studies specifically examine develop-mental consequences of early exposures to untested chemicals, sub-clinical dysfunction caused by these exposures can go unrecognized for years. One example is the “silent epidemic” of childhood lead poisoning: From the 1940s to the 1980s, millions of American children were exposed to excessive levels of lead from paint and gasoline, resulting in reduced average intelligence by 2–5 IQ points (Grosse et al. 2002). The late David Rall, former director of NIEHS, once observed that “If thalidomide had caused a 10-point loss of IQ instead of birth defects of the limbs, it would likely still be on the market” (Weiss 1982).

To begin formulation of a systematic strategy for discovery of potentially preventable environmental causes of autism and other NDDs, the Mount Sinai Children’s Environmental Health Center, with the support of the NIEHS and Autism Speaks, convened a workshop on “Exploring the Environmental Causes of Autism and Learning Disabilities.” This workshop produced a series of papers by leading researchers, some of which are published in this issue of Environmental Health Perspectives. It also generated a list of 10 chemi-cals and mixtures widely distributed in the environment that are already suspected of causing develop-mental neuro-toxicity:

This list is not exhaustive and will almost certainly expand in the years ahead as new science emerges. It is intended to focus research in environmental causation of NDDs on a short list of chemicals where concentrated study has high potential to generate actionable findings in the near future. Its ultimate purpose is to catalyze new evidence-based programs for prevention of disease in America’s children.

The authors declare they have no actual or potential competing -financial interests.


  • Anway MD, Skinner MK. 2006. Epigenetic transgenerational actions of endocrine disruptors.Endocrinology 147(6) supplS43-S4916690803. Crossref, MedlineGoogle Scholar
  • Arndt TL, Stodgell CJ, Rodier PM. 2005. The teratology of autism.Int J Dev Neurosci 23:189-19915749245. Crossref, MedlineGoogle Scholar
  • Autism Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, et al2007. Mapping autism risk loci using genetic linkage and chromosomal rearrangements.Nat Genet 39:319-32817322880. Crossref, MedlineGoogle Scholar
  • Braun JM, Kalkbrenner AE, Calafat AM, Yolton K, Ye X, Dietrich KNet al.. 2011. Impact of early-life bisphenol A exposure on behavior and executive function in children.Pediatrics 128(5):873-88222025598. Crossref, MedlineGoogle Scholar
  • Buxbaum JD, Hof PR. 2011. The emerging neuroscience of autism spectrum disorders. [Editorial]Brain Res 1380:1-221356391. Crossref, MedlineGoogle Scholar
  • CDC (Centers for Disease Control and Prevention)2005. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder–United States, 2003.MMWR Morb Mortal Wkly Rep 54:842-84716138075. MedlineGoogle Scholar
  • CDC (Centers for Disease Control and Prevention)2012. Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, 14 sites, United States, 2008.MMWR Surveill Summ 61(3):1-19. Google Scholar
  • Daniels JL. 2006. Autism and the environment. [Editorial]Environ Health Perspect 114:A39616835036. LinkGoogle Scholar
  • Eskenazi B, Marks AR, Bradman A, Harley K, Barr DB, Johnson Cet al.. 2007. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children.Environ Health Perspect 115:792-79817520070. LinkGoogle Scholar
  • Eskenazi B, Rosas LG, Marks AR, Bradman A, Harley K, Holland Net al.. 2008. Pesticide toxicity and the developing brain.Basic Clin Pharmacol Toxicol 102(2):228-23618226078. Crossref, MedlineGoogle Scholar
  • Fernandez TV, Sanders SJ, Yurkiewicz IR, Ercan-Sencicek AG, Kim YS, Fishman DOet al.. 2012. Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism.Biol Psychiatry 71(5):392-40222169095. Crossref, MedlineGoogle Scholar
  • Goldman LR. 1998. Chemicals and children’s environment: what we don’t know about risks.Environ Health Perspect 106(suppl 3):875-8809646051. LinkGoogle Scholar
  • Grafodatskaya D, Chung B, Szatmari P, Weksberg R.. 2010. Autism spectrum disorders and epigenetics.J Am Acad Child Adolesc Psychiatry 49(8):794-80920643313. Crossref, MedlineGoogle Scholar
  • Grandjean P, Landrigan PJ. 2006. Developmental neurotoxicity of industrial chemicals: a silent pandemic.Lancet 368(9553):2167-217817174709. Crossref, MedlineGoogle Scholar
  • Grosse SD, Matte TD, Schwartz J, Jackson RJ. 2002. Economic gains resulting from the reduction in children’s exposure to lead in the United States.Environ Health Perspect 110:563-56912055046. LinkGoogle Scholar
  • Herbstman JB, Sjödin A, Kurzon M, Lederman SA, Jones RS, Rauh Vet al.. 2010. Prenatal exposure to PBDEs and neurodevelopment.Environ Health Perspect 118:712-71920056561. LinkGoogle Scholar
  • Jusko TA, Henderson CR, Lanphear BP, Cory-Slechta DA, Parsons PJ, Canfield RL. 2008. Blood lead concentrations < 10 µg/dL and child intelligence at 6 years of age.Environ Health Perspect 116:243-24818288325. LinkGoogle Scholar
  • Khan K, Factor-Litvak P, Wasserman GA, Liu X, Ahmed E, Parvez Fet al.. 2011. Manganese exposure from drinking water and children’s classroom behavior in Bangladesh.Environ Health Perspect 119:1501-150621493178. LinkGoogle Scholar
  • Landrigan PJ, Goldman LR. 2011. Children’s vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy.Health Aff 30(5):842-850. CrossrefGoogle Scholar
  • London L, Beseler C, Bouchard MF, Bellinger DC, Colosio C, Grandjean Pet al.. 2012. Neurobehavioral and neurodevelopmental effects of pesticide exposures.Neurotoxicology [Online 17 January 2012]. Google Scholar
  • Miodovnik A.. 2011. Environmental neurotoxicants and developing brain.Mt Sinai J Med 78(1):58-7721259263. Crossref, MedlineGoogle Scholar
  • Miodovnik A, Engel SM, Zhu C, Ye X, Soorya LV, Silva MJet al.. 2011. Endocrine disruptors and childhood social impairment.Neurotoxicology 32(2):261-26721182865. Crossref, MedlineGoogle Scholar
  • National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment.Washington, DC:National Academy Press. Google Scholar
  • Oken E, Radesky JS, Wright RO, Bellinger DC, Amarasiriwardena CJ, Kleinman KPet al.. 2008. Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort.Am J Epidemiol 167(10):1171-118118353804. Crossref, MedlineGoogle Scholar
  • O’Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan Set al.. 2011. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.Nat Genet 43:585-58921572417. Crossref, MedlineGoogle Scholar
  • Pastor PN, Reuben CA. 2008. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004–2006.Vital Health Stat 10 (237):1-1418998276. MedlineGoogle Scholar
  • Perera FP, Li Z, Whyatt R, Hoepner L, Wang S, Camann Det al.. 2009. Prenatal airborne polycyclic aromatic hydrocarbon exposure and child IQ at age 5 years.Pediatrics 124(2):e195-e202; doi:10.1542/peds.2008-3506[Online 20 July 2009)19620194. Crossref, MedlineGoogle Scholar
  • Sakurai T, Cai G, Grice DE, Buxbaum JD. 2011. Genomic architecture of autism spectrum disorders.In: Textbook of Autism Spectrum Disorders (Hollander E, Kolevzon A, Coyle JT. eds)Washington, DC:American Psychiatric Publishing281-298. Google Scholar
  • Stein CR, Savitz DA. 2011. Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5–18 years of age.Environ Health Perspect 119:1466-147121665566. LinkGoogle Scholar
  • Trasande L, Liu Y.. 2011. Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008.Health Aff 30(5):863-870. CrossrefGoogle Scholar
  • Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R. 2011. Residential proximity to freeways and autism in the CHARGE Study.Environ Health Perspect 119:873-87721156395. LinkGoogle Scholar
  • Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, Kline Jet al.. 2007. Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh.Environ Health Perspect 115:285-28917384779. LinkGoogle Scholar
  • Waterland RA, Jirtle RL. 2004. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases.Nutrition 20:63-6814698016. Crossref, MedlineGoogle Scholar
  • Weiss B.. 1982. Food additives and environmental chemicals as sources of childhood behavior disorders.J Am Acad Child Psychiatry 21:144-1527069080. Crossref, MedlineGoogle Scholar
  • Winneke G.. 2011. Developmental aspects of environmental neurotoxicology: lessons from lead and polychlorinated biphenyls.J Neurol Sci 308(1-2):9-1521679971. Crossref, MedlineGoogle Scholar
  • Woodruff TJ, Zota AR, Schwartz JM. 2011. Environmental chemicals in pregnant women in the United States: NHANES 2003–2004.Environ Health Perspect 119:878-88521233055. LinkGoogle Scholar